Relative Bioavailability Study of HU6

NCT06486558 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HU6 450 mg Tablet
DRUG: HU6 150 mg Capsules x 3 (Total dose = 450 mg)

Sponsor

Rivus Pharmaceuticals, Inc.